Skip to Main Content

Author Details

Cuong Hoang-Vu
Center for Cancer Research, National Cancer Institute
1985
212
47
PMIDPaper TitleJournal TitlePublished Year
36456359Current status of National Institutes of Health funding for thoracic surgeons in the United States: Beacon of hope or candle in the wind?J Thorac Cardiovasc Surg2024
36769844Influence of Ascorbic Acid as a Growth and Differentiation Factor on Dental Stem Cells Used in Regenerative Endodontic Therapies.J Clin Med2023
37883246Low level of tonic interferon signalling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids.Emerg Microbes Infect2023
37608989A Unique Gene Signature Predicting Recurrence Free Survival in Stage IA Lung Adenocarcinoma.J Thorac Cardiovasc Surg2023
37974213Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy.J Exp Clin Cancer Res2023
37296836Preclinical Models of Adrenocortical Cancer.Cancers (Basel)2023
36870293Cigarette Smoke Enhances the Malignant Phenotype of Esophageal Adenocarcinoma Cells by Disrupting a Repressive Regulatory Interaction Between miR-145 and LOXL2.Lab Invest2023
34004296Commentary: Fibroblasts are Incredible and Versatile - Like the Edible Egg?Semin Thorac Cardiovasc Surg2022
35586499Current State of Pleural-Directed Adjuncts Against Malignant Pleural Mesothelioma.Front Oncol2022
35403059Commentary: Radiofrequency identification of pulmonary nodules: Is there an app for that?JTCVS Tech2022
35462085Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.J Thorac Oncol2022
35749374Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.Cancer Immunol Res2022
37323368Promising therapeutic potential of tumor suppressor microRNAs for malignant pleural mesothelioma.J Cancer Metastasis Treat2022
35104158Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes.J Clin Oncol2022
34601587A scoping review of artificial intelligence applications in thoracic surgery.Eur J Cardiothorac Surg2022
32513486Commentary: Smoke or fire? Resected lung cancer in never-smokers.J Thorac Cardiovasc Surg2021
36003178Commentary: Meta-analysis of postoperative radiotherapy in N2-positive lung cancer-Garbage in, garbage out?JTCVS Open2021
33809272Osteocalcin, Osteopontin and RUNX2 Expression in Patients' Leucocytes with Arteriosclerosis.Diseases2021
34556833Surface-fill hydrogel attenuates the oncogenic signature of complex anatomical surface cancer in a single application.Nat Nanotechnol2021
34790904Hookah Smoke Mediates Cancer-Associated Epigenomic and Transcriptomic Signatures in Human Respiratory Epithelial Cells.JTO Clin Res Rep2021
34586369Characterization of Outcomes by Surgical Management of Lung Neuroendocrine Tumors Associated With Cushing Syndrome.JAMA Netw Open2021
34430349Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies.Transl Lung Cancer Res2021
34137798Typical Kidney Tumor With Atypical Presentation.JAMA Oncol2021
33996251MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis.Mol Ther Nucleic Acids2021
33380218Mouse models for mesothelioma drug discovery and development.Expert Opin Drug Discov2021
33378696Characteristics of Matriculants to Thoracic Surgery Residency Training Programs.Ann Thorac Surg2021
33181298Commentary: Keeping Both Techniques Up One's Sleeve: VATS and Open Sleeve Lobectomy.Semin Thorac Cardiovasc Surg2021
32977970Commentary: To sleeve or not to sleeve: Still a question?J Thorac Cardiovasc Surg2021
32580902Commentary: Keeping the target painted for precision cancer therapy.J Thorac Cardiovasc Surg2021
32927122UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.J Thorac Oncol2021
31570787Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1.Oncogene2020
31847529Angiotensin converting enzymes ACE and ACE2 in thyroid cancer progression.Neoplasma2020
32726133Normal mesothelial cell lines newly derived from human pleural biopsy explants.Am J Physiol Lung Cell Mol Physiol2020
32362388Commentary: Pigmented spot during esophagoscopy-a mole or melanoma?J Thorac Cardiovasc Surg2020
32113722Commentary: Surgeon versus mesothelioma in a thoracic cage match.J Thorac Cardiovasc Surg2020
32381040A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk.Genome Biol2020
32569648Commentary: Robotics to Reclaim the First Rib From No Man's Land?Semin Thorac Cardiovasc Surg2020
32483558Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer.Cell Rep Med2020
31054476Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated Signaling.Transl Oncol2019
31227395MicroRNA-215-5p Treatment Suppresses Mesothelioma Progression via the MDM2-p53-Signaling Axis.Mol Ther2019
29219888Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors.J Thorac Imaging2018
30107926Adjuvant chemotherapy in stage I lung cancer: Is more better?J Thorac Cardiovasc Surg2018
29934340Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma.Mol Cancer Ther2018
30325352A radiogenomic dataset of non-small cell lung cancer.Sci Data2018
29455965What the nose knows: Trends in biomimetic sensor technology.J Thorac Cardiovasc Surg2018
29653751Esophageal injury: Tissue is always the issue.J Thorac Cardiovasc Surg2018
27780780Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer.J Thorac Oncol2017
28139704Predictive radiogenomics modeling of EGFR mutation status in lung cancer.Sci Rep2017
28385276Corrigendum to "Epidermal Growth Factor Cytoplasmic Domain Affects ErbB Protein Degradation by the Lysosomal and Ubiquitin-Proteasome Pathway in Human Cancer Cells" [Neoplasia 14 (2012) 396-409].Neoplasia2017
28359577Resection of pulmonary sarcomatous metastases: Cut to cure?J Thorac Cardiovasc Surg2017
  • 1 - 50 of 212

Recommended Authors

Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 9
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 0
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 4
Luc G T Morris
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Patrizia Moser
Medical University of Innsbruck
Career Start Year 1999
Number of shared co-authors 0
Woo Young Kim
Westchester Medical Center
Career Start Year 1998
Number of shared co-authors 1
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 0
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 11
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 2
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 1
Dhaval Patel
National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 6
Matthew D Ringel
The Ohio State University College of Medicine and Comprehensive Cancer Center
Career Start Year 1991
Number of shared co-authors 2
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1989
Number of shared co-authors 2
Thomas J Giordano
University of Michigan ann arbor
Career Start Year 1989
Number of shared co-authors 1
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 1
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 1
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 0
Francisco X Real
Spanish National Cancer Research Centre-CNIO
Career Start Year 1983
Number of shared co-authors 1
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 5
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 4
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 3
Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 0
David M Thomas
Garvan Institute of Medical Research
Career Start Year 1980
Number of shared co-authors 1
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 17
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 1
Ming-Sound Tsao
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 3

Collaborators

David S Schrump
Center for Cancer Research, National Cancer Institute
Co-authored papers 17
Kenneth P Seastedt
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 6
Daniel L Rubin
Stanford University.
Co-authored papers 5
Mary Zhang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Sichuan Xi
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Christian Mawrin
Co-authored papers 4
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Co-authored papers 4
E Alejandro Sweet-Cordero
University of California San Francisco
Co-authored papers 3
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Shaojian Gao
Co-authored papers 3
Sudheer Kumar Gara
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Vivek Shukla
Chalmers University of Technology
Co-authored papers 3
Atul J Butte
Bakar Computational Health Sciences Institute, University of California san francisco
Co-authored papers 2
Arun Rajan
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Bernhard O Boehm
Co-authored papers 2
Julie A Hong
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Todd D Prickett
National Cancer Institute
Co-authored papers 2
Martin Hrab?? de Angelis
German Center for Diabetes Research (DZD e.V.)
Co-authored papers 2
Satyajit Ray
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Udayan Guha
Co-authored papers 2
Naris Nilubol
Center for Cancer Research
Co-authored papers 2
Catharine M L West
University of Manchester
Co-authored papers 2
Jared J Gartner
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Markku Miettinen
National Cancer Institute
Co-authored papers 2
Aaron M Newman
Stanford University
Co-authored papers 2
Raphael Bueno
Co-authored papers 2
Purvesh Khatri
University of California San Francisco
Co-authored papers 2
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 2
Leanne C Sayles
Co-authored papers 2
Emily S Reardon
Center for Cancer Research National Cancer Institute, National Institutes of Health
Co-authored papers 2
Release 1.2